Global Digital Subtraction Angiography System Market Strategic Research Report

Scope of the Report

The global Digital Subtraction Angiography System market size is predicted to grow from US$ 5,232 million in 2025 to US$ 7,794 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

In 2025, global digital subtraction angiography (DSA) system production reached approximately 4535 units, with an average global market price of around K US$ 1179 per unit. Digital subtraction angiography system is an advanced medical imaging system combining X-ray imaging and computer processing technology. It is mainly used to clearly display vascular structure and diagnose vascular diseases. Its core principle is to eliminate background interference such as bone and soft tissue through digital processing, and only retain the vascular image filled with contrast agent, thus providing high-contrast vascular dynamic images.

Market Concentration and Key Players:

Internationally, the market concentration degree of digital subtraction angiography system is relatively high, mainly concentrated on Europe, America and other developed countries. For example, Philips, Siemens Medical and other large manufacturers; from the domestic perspective, digital subtraction angiography systems include Shanghai UIH Medical Technology and Neusoft Medical, etc.

Manufacturing Processes and Market Trends:

The manufacturing process of digital subtraction angiography system is highly dependent on precision electromechanical integration and algorithm optimization. Its core process covers the design and packaging of high-precision X-ray tube and flat panel detector, dual-channel real-time image processing system and intelligent control unit. The process difficulty lies in the localization lag of core components. For example, the import dependence of flat panel detector is as high as 80%, and it shall strictly comply with the radiation safety and imaging quality standards of NMPA, FDA and other institutions.

The market trend shows technology integration and regional differentiation: at the technical level, AI algorithm and low-dose imaging technology have become the focus of competition, the equipment is developing towards lightweight and multifunctional integration, supporting multi-modality fusion and remote operation, and 3D vascular reconstruction technology improves the accuracy of diagnosis and treatment; In terms of regional demand, the European and American markets mainly focus on high-end equipment renewal, while the Asia-Pacific region (especially China) has become the growth engine due to the accelerated aging and the penetration of primary medical care. Affected by medical anti-corruption and centralized procurement and price reduction, the price of middle and low-end equipment has dropped; Domestic substitution accelerates, UIH uAngio AVIVA has been certified by FDA to mark domestic technology entering the global market and promote the localization of industrial chain), but short-term supply chain disturbances (such as chip control) still restrict capacity release.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Digital Subtraction Angiography System market?

What factors are driving Digital Subtraction Angiography System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Digital Subtraction Angiography System market opportunities vary by end market size?

How does Digital Subtraction Angiography System break out by Structure, by Application?

This report presents a comprehensive overview of the global Digital Subtraction Angiography System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Structure

• Floor-standing C-arm System
• Suspended C-arm System
• Bidirectional C-arm System

Segment by Plane

• Single-plane
• Biplane

Segment by Mobile

• Fixed
• Mobile

Segment by Application

• CVD
• Neurovascular Disease
• Interventional Therapy of Tumor
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Digital Subtraction Angiography System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in CVD, Neurovascular Disease, Interventional Therapy of Tumor evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact